
Alignment Healthcare upgraded to Buy after strong Q2 results and 40%+ upside potential despite valuation drop.
Alignment Healthcare has been upgraded from Hold to Buy following a 38% valuation-driven price drop, despite strong operational performance. The company reported record-low medical benefits ratio, 31% membership growth, and 48% adjusted EBITDA growth...



